{"id":"https://openalex.org/W2153673383","doi":"https://doi.org/10.2174/092986711797287557","title":"Squalene Synthase Inhibitors: An Update on the Search for New Antihyperlipidemic and Antiatherosclerotic Agents","display_name":"Squalene Synthase Inhibitors: An Update on the Search for New Antihyperlipidemic and Antiatherosclerotic Agents","publication_year":2011,"publication_date":"2011-09-09","ids":{"openalex":"https://openalex.org/W2153673383","doi":"https://doi.org/10.2174/092986711797287557","mag":"2153673383","pmid":"https://pubmed.ncbi.nlm.nih.gov/21864285"},"language":"en","primary_location":{"id":"doi:10.2174/092986711797287557","doi":"https://doi.org/10.2174/092986711797287557","is_oa":false,"landing_page_url":"https://doi.org/10.2174/092986711797287557","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046876821","display_name":"Angeliki P. Kourounakis","orcid":"https://orcid.org/0000-0002-8151-311X","observed_orcids":["https://orcid.org/0000-0002-8151-311X"]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"A. P. Kourounakis","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, 15771 Athens, Greece. angeliki@pharm.uoa.gr","Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, 15771 Athens, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, 15771 Athens, Greece. angeliki@pharm.uoa.gr","institution_ids":["https://openalex.org/I200777214"]},{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, 15771 Athens, Greece","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057206933","display_name":"Maria G. Katselou","orcid":"https://orcid.org/0000-0003-4269-6555","observed_orcids":["https://orcid.org/0000-0003-4269-6555"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. G. Katselou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085187021","display_name":"Alexios N. Matralis","orcid":"https://orcid.org/0000-0001-6863-1931","observed_orcids":["https://orcid.org/0000-0001-6863-1931"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. N. Matralis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034337124","display_name":"Eleni M. Ladopoulou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"E. M. Ladopoulou","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, 15771 Athens, Greece.,Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, 15771 Athens, Greece.,Greece","institution_ids":["https://openalex.org/I200777214"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108487210","display_name":"Eugenia I. Bavavea","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200777214","display_name":"National and Kapodistrian University of Athens","ror":"https://ror.org/04gnjpq42","country_code":"GR","type":"education","lineage":["https://openalex.org/I200777214"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"E. Bavavea","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, 15771 Athens, Greece.,Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, 15771 Athens, Greece.,Greece","institution_ids":["https://openalex.org/I200777214"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3313,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.77555743,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"18","issue":"29","first_page":"4418","last_page":"4439"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.823199987411499,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.823199987411499,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.14830000698566437,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.01769999973475933,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/squalene-synthase-inhibitors","display_name":"squalene synthase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/cholesterol-synthesis","display_name":"cholesterol biosynthesis","score":0.8889999985694885},{"id":"https://openalex.org/keywords/hypocholesterolemic-agents","display_name":"hypocholesterolemic agents","score":0.8920000195503235},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.7950000166893005},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9509999752044678},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7070000171661377},{"id":"https://openalex.org/keywords/benzoxazepine-derivatives","display_name":"benzoxazepine derivatives","score":0.8330000042915344},{"id":"https://openalex.org/keywords/zaragozic-acids","display_name":"zaragozic acid","score":0.7829999923706055},{"id":"https://openalex.org/keywords/quinuclidine-derivatives","display_name":"quinuclidine derivatives","score":0.8830000162124634},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C2776703722","wikidata":"https://www.wikidata.org/wiki/Q407560","display_name":"Squalene","level":2,"score":0.9008432626724243},{"id":"https://openalex.org/C2779716203","wikidata":"https://www.wikidata.org/wiki/Q410600","display_name":"Farnesyl-diphosphate farnesyltransferase","level":5,"score":0.8692476153373718},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6001128554344177},{"id":"https://openalex.org/C553450214","wikidata":"https://www.wikidata.org/wiki/Q851162","display_name":"Biosynthesis","level":3,"score":0.5315656065940857},{"id":"https://openalex.org/C134651460","wikidata":"https://www.wikidata.org/wiki/Q3100717","display_name":"Reductase","level":3,"score":0.5226759314537048},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.5034269690513611},{"id":"https://openalex.org/C112243037","wikidata":"https://www.wikidata.org/wiki/Q22327117","display_name":"ATP synthase","level":3,"score":0.48632651567459106},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.45859992504119873},{"id":"https://openalex.org/C2779123261","wikidata":"https://www.wikidata.org/wiki/Q407635","display_name":"Coenzyme A","level":4,"score":0.4575566053390503},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.45422011613845825},{"id":"https://openalex.org/C104950815","wikidata":"https://www.wikidata.org/wiki/Q415607","display_name":"HMG-CoA reductase","level":4,"score":0.4141940772533417},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3344198167324066},{"id":"https://openalex.org/C2778396349","wikidata":"https://www.wikidata.org/wiki/Q410994","display_name":"Farnesyltransferase","level":4,"score":0.17027732729911804},{"id":"https://openalex.org/C57790582","wikidata":"https://www.wikidata.org/wiki/Q901141","display_name":"Prenylation","level":3,"score":0.10083460807800293}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013186","descriptor_name":"Farnesyl-Diphosphate Farnesyltransferase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013186","descriptor_name":"Farnesyl-Diphosphate Farnesyltransferase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/092986711797287557","doi":"https://doi.org/10.2174/092986711797287557","is_oa":false,"landing_page_url":"https://doi.org/10.2174/092986711797287557","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:21864285","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21864285","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2198992724","https://openalex.org/W1871067114","https://openalex.org/W2082949986","https://openalex.org/W2027486144","https://openalex.org/W2062033942","https://openalex.org/W2351457514","https://openalex.org/W2106895490","https://openalex.org/W2003232521","https://openalex.org/W2033382359","https://openalex.org/W2182810510"],"abstract_inverted_index":{"Atherosclerosis":[0],"and":[1,38,96,127,153,185,228,256],"related":[2],"heart":[3],"disease":[4],"is":[5,74,140,159],"strongly":[6],"associated":[7],"with":[8,145],"elevated":[9],"blood":[10],"levels":[11],"of":[12,26,40,79,89,98,100,114,117,134,148,166,201,234,239,248],"total":[13],"(and":[14],"LDL)":[15],"cholesterol.":[16],"Due":[17],"to":[18,93,143,225],"the":[19,36,44,66,75,83,94,106,118,125,132,135,146,223,231,241,246],"widespread":[20],"incidence":[21],"as":[22,24,56,85,87,172,189,191,198,258,260],"well":[23,86,190,259],"severity":[25],"this":[27,219,235],"pathological":[28],"condition,":[29],"major":[30],"efforts":[31,244],"have":[32,91,195],"been":[33,196,212],"made":[34],"for":[35,161],"discovery":[37,243],"development":[39,247],"hypocholesteroleamic":[41],"agents.":[42],"In":[43,218],"past":[45],"few":[46],"decades,":[47],"HMG-CoA":[48],"reductase":[49,71],"inhibitors":[50,99,121,169,200],"(statins)":[51],"are":[52],"being":[53],"extensively":[54],"used":[55],"lipid":[57],"lowering":[58],"drugs.":[59],"These":[60],"agents":[61,115],"act":[62,123],"predominantly":[63],"by":[64],"inhibiting":[65],"enzyme":[67],"3-hydroxy-3-methylglutaryl":[68],"coenzyme":[69],"A":[70],"(HMGR)":[72],"that":[73],"rate":[76],"limiting":[77],"step":[78,130],"cholesterol":[80,108,136],"biosynthesis.":[81],"Both":[82],"success":[84],"drawbacks":[88],"HMGRIs,":[90],"led":[92],"investigation":[95],"design":[97],"other":[101,149],"(downstream)":[102],"enzymes":[103],"involved":[104],"in":[105,214],"multistep":[107],"biosynthetic":[109],"pathway.":[110],"One":[111],"such":[112,171],"class":[113,238],"consists":[116],"squalene":[119,167,202,250],"sythase":[120],"which":[122],"at":[124],"first":[126],"solely":[128],"committed":[129],"towards":[131,245],"biosynthesis":[133,147],"nucleus.":[137],"This":[138],"target":[139],"considered":[141],"not":[142],"interfere":[144],"biologically":[150],"important":[151],"molecules":[152],"thus":[154],"a":[155],"better":[156],"side-effect":[157],"profile":[158,255],"expected":[160],"these":[162],"inhibitors.":[163],"Several":[164],"classes":[165],"synthase":[168,251],"(SQSIs),":[170],"substrate":[173],"or":[174,179],"transition-state":[175],"analogues,":[176],"zaragozic":[177],"acids":[178],"2,8-":[180],"dioxabicyclo[3.2.1]octane":[181],"derivatives,":[182,187,194],"dicarboxylic":[183],"acid":[184],"quinuclidine":[186],"4,1-benzoxazepine":[188],"substituted":[192],"morpholine":[193],"studied":[197],"potent":[199],"synthase.":[203],"So":[204],"far":[205],"only":[206],"one":[207],"benzoxazepine":[208],"derivative":[209],"(TAK-475)":[210],"has":[211],"evaluated":[213],"advanced":[215],"clinical":[216],"trials.":[217],"article":[220],"we":[221],"review":[222],"up":[224],"date":[226],"research":[227],"literature":[229],"on":[230],"therapeutic":[232],"potential":[233],"relatively":[236],"new":[237],"compounds,":[240],"drug":[242],"active":[249],"inhibitors,":[252],"their":[253,261],"activity":[254],"effectiveness,":[257],"structure-activity":[262],"relationships.":[263]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}